These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review. Giuffrè M; Merli N; Pugliatti M; Moretti R Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542310 [TBL] [Abstract][Full Text] [Related]
3. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis. Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312 [TBL] [Abstract][Full Text] [Related]
4. Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease? Gehrke N; Schattenberg JM Gastroenterology; 2020 May; 158(7):1929-1947.e6. PubMed ID: 32068022 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. Lim S; Oh TJ; Koh KK Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987 [TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Asrih M; Jornayvaz FR Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480 [TBL] [Abstract][Full Text] [Related]
7. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. Abenavoli L; Milic N; Di Renzo L; Preveden T; Medić-Stojanoska M; De Lorenzo A World J Gastroenterol; 2016 Aug; 22(31):7006-16. PubMed ID: 27610012 [TBL] [Abstract][Full Text] [Related]
8. Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial. Chen Y; Feng R; Yang X; Dai J; Huang M; Ji X; Li Y; Okekunle AP; Gao G; Onwuka JU; Pang X; Wang C; Li C; Li Y; Sun C Am J Clin Nutr; 2019 Jun; 109(6):1611-1619. PubMed ID: 31136662 [TBL] [Abstract][Full Text] [Related]
9. Environmental Microcystin exposure in underlying NAFLD-induced exacerbation of neuroinflammation, blood-brain barrier dysfunction, and neurodegeneration are NLRP3 and S100B dependent. Mondal A; Saha P; Bose D; Chatterjee S; Seth RK; Xiao S; Porter DE; Brooks BW; Scott GI; Nagarkatti M; Nagarkatti P; Chatterjee S Toxicology; 2021 Sep; 461():152901. PubMed ID: 34416350 [TBL] [Abstract][Full Text] [Related]
10. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes. Bayliss J; Ooi GJ; De Nardo W; Shah YJH; Montgomery MK; McLean C; Kemp W; Roberts SK; Brown WA; Burton PR; Watt MJ Front Endocrinol (Lausanne); 2021; 12():642432. PubMed ID: 33746906 [TBL] [Abstract][Full Text] [Related]
11. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Santos RD; Valenti L; Romeo S Atherosclerosis; 2019 Mar; 282():110-120. PubMed ID: 30731283 [TBL] [Abstract][Full Text] [Related]
12. Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis. Xu X; Lu L; Dong Q; Li X; Zhang N; Xin Y; Xuan S Lipids Health Dis; 2015 Dec; 14():158. PubMed ID: 26631018 [TBL] [Abstract][Full Text] [Related]
13. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. Sunny NE; Kalavalapalli S; Bril F; Garrett TJ; Nautiyal M; Mathew JT; Williams CM; Cusi K Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E311-9. PubMed ID: 26058864 [TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH). Ota T Adv Exp Med Biol; 2021; 1261():223-229. PubMed ID: 33783745 [TBL] [Abstract][Full Text] [Related]